JBM (Healthcare) Ltd. (HK:2161) has released an update.
JBM (Healthcare) Ltd. has revised its Audit Committee’s terms of reference, aiming to bolster transparency and efficacy in financial reporting, risk management, and internal controls. The committee, primarily composed of independent non-executive directors, will meet at least biannually and work closely with external auditors to ensure robust oversight. The revisions, which include provisions to prevent conflicts of interest, underscore the company’s commitment to upholding high standards of corporate governance.
For further insights into HK:2161 stock, check out TipRanks’ Stock Analysis page.
